GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Basilea Pharmaceutica Ltd (XSWX:BSLN) » Definitions » Pretax Margin %

Basilea Pharmaceutica (XSWX:BSLN) Pretax Margin % : -29.43% (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Basilea Pharmaceutica Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Basilea Pharmaceutica's Pre-Tax Income for the six months ended in Dec. 2023 was CHF-21.4 Mil. Basilea Pharmaceutica's Revenue for the six months ended in Dec. 2023 was CHF72.7 Mil. Therefore, Basilea Pharmaceutica's pretax margin for the quarter that ended in Dec. 2023 was -29.43%.

The historical rank and industry rank for Basilea Pharmaceutica's Pretax Margin % or its related term are showing as below:

XSWX:BSLN' s Pretax Margin % Range Over the Past 10 Years
Min: -116.46   Med: -17.7   Max: 8.19
Current: 6.64


XSWX:BSLN's Pretax Margin % is ranked better than
80.16% of 1028 companies
in the Biotechnology industry
Industry Median: -155.495 vs XSWX:BSLN: 6.64

Basilea Pharmaceutica Pretax Margin % Historical Data

The historical data trend for Basilea Pharmaceutica's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Basilea Pharmaceutica Pretax Margin % Chart

Basilea Pharmaceutica Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -16.66 -11.49 -4.59 8.19 6.64

Basilea Pharmaceutica Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.93 -21.20 26.99 37.53 -29.43

Competitive Comparison of Basilea Pharmaceutica's Pretax Margin %

For the Biotechnology subindustry, Basilea Pharmaceutica's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Basilea Pharmaceutica's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Basilea Pharmaceutica's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Basilea Pharmaceutica's Pretax Margin % falls into.



Basilea Pharmaceutica Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Basilea Pharmaceutica's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=10.461/157.634
=6.64 %

Basilea Pharmaceutica's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-21.406/72.729
=-29.43 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Basilea Pharmaceutica  (XSWX:BSLN) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Basilea Pharmaceutica Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Basilea Pharmaceutica's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Basilea Pharmaceutica (XSWX:BSLN) Business Description

Traded in Other Exchanges
Address
Switzerland Innovation Park, Basel Area, Main Campus, Near Basel, Allschwil, CHE, 4058
Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing drugs to meet the needs of patients with severe bacterial and fungal infections. The Company has operating subsidiaries in the United Kingdom and Germany. Geographically company derives revenue from Japan, Ireland, Republic of Korea, USA, Uruguay, Sweden, Canada, Jordan, Switzerland and Other countries.

Basilea Pharmaceutica (XSWX:BSLN) Headlines

No Headlines